- We will send in 10–14 business days.
/images/books/10413505/9781496025593.jpg)
- Author: U S Department of Commerce
- Publisher: CreateSpace Independent Publishing Platform
- Year: 2004
- Pages: 124
- ISBN-10: 1496025598
- ISBN-13: 9781496025593
- Format: 21.6 x 28 x 0.7 cm, softcover
- Language: English
- SAVE -10% with code: EXTRA
Pharmaceutical Price Controls in OECD Countries (e-book) (used book) | bookbook.eu
Reviews
Description
This report details the effect of price controls imposed by various U.S. trade partners on pharmaceutical prices, R&D, innovation, and U.S. consumers. The study examined the drug price regulatory systems of 11 OECD countries. A quantitative analysis of prices, revenues, and R&D effects based on available data was also conducted for nine OECD countries. For reasons explained in the report, two of these nine countries were excluded from further consideration. The results from the remaining six countries were then extrapolated to the total patented markets of five additional OECD countries. Thus, the final estimates of the impact of price controls on R&D and innovation are based on an analysis of 11 OECD countries.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 20d.00:20:27
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Author: U S Department of Commerce
- Publisher: CreateSpace Independent Publishing Platform
- Year: 2004
- Pages: 124
- ISBN-10: 1496025598
- ISBN-13: 9781496025593
- Format: 21.6 x 28 x 0.7 cm, softcover
- Language: English English
This report details the effect of price controls imposed by various U.S. trade partners on pharmaceutical prices, R&D, innovation, and U.S. consumers. The study examined the drug price regulatory systems of 11 OECD countries. A quantitative analysis of prices, revenues, and R&D effects based on available data was also conducted for nine OECD countries. For reasons explained in the report, two of these nine countries were excluded from further consideration. The results from the remaining six countries were then extrapolated to the total patented markets of five additional OECD countries. Thus, the final estimates of the impact of price controls on R&D and innovation are based on an analysis of 11 OECD countries.
Reviews